Graft Function/Survival
1 clinical trials · Condition
◉ Watch Graft Function/Survival
| Record | Firm | Date |
|---|---|---|
| Rituximab in Renal Allograft Recipients Who Develop Early De Novo Anti-HLA Alloantibodies (NCT00307125) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-03-01 |
Track Graft Function/Survival automatically
Every clearance here is in the API, with alerts when new ones post.